374Water Inc. Form 10-K Summary
Business context and reporting period
This filing covers the fiscal year ended December 31, 2023. 374Water is an early-stage cleantech company developing AirSCWO supercritical water oxidation systems that treat wet wastes, including municipal sludge, biosolids, food waste, hazardous waste and certain PFAS-containing streams, while seeking to recover water, energy and minerals. The company generates revenue from equipment manufacturing and treatability studies and expects to pursue equipment sales, service agreements and channel-partner arrangements.
The company is a smaller reporting company and emerging growth company. It had 26 full-time employees and six consultants at year-end and reported 132,667,107 common shares outstanding as of March 29, 2024.
Financial performance and liquidity
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $743,952 | $3,015,521 | Down 75% |
| Cost of revenues | $1,852,208 | $2,679,020 | Down 31% |
| Gross profit (loss) | $(1,108,256) | $336,501 | Down $1,444,757 |
| Operating expenses | $7,534,620 | $5,092,632 | Up 48% |
| Loss from operations | $(8,642,876) | $(4,756,131) | Loss increased 82% |
| Other income, net | $539,354 | $66,164 | Up 715% |
| Net loss | $(8,103,522) | $(4,689,967) | Loss increased 73% |
| Net loss per share | $(0.06) | $(0.04) |
Revenue consisted of $655,818 of equipment revenue and $88,134 of service revenue. The approximate gross margin was negative 149% in 2023 versus approximately 11% in 2022; the filing does not present adjusted or non-GAAP margin measures. Research and development expense increased 34% to $1.50 million, compensation and related expense increased 74% to $2.85 million, and general and administrative expense increased 71% to $2.68 million. Professional fees declined 34% to $508,795.
Cash used in operating activities was $9.03 million, compared with $4.95 million in 2022. Investing activities provided $1.85 million, primarily from the maturity of investment securities. Financing activities provided $13.58 million, including $13.44 million of net proceeds from the at-the-market equity offering. Cash and cash equivalents were $10.45 million at year-end, compared with $4.05 million in 2022. Working capital was $13.53 million, compared with $7.06 million in 2022.
The balance sheet shows total liabilities of $1.37 million and no debt balance is disclosed. Current liabilities included a $500,000 accrued contract loss provision, a $135,000 accrued legal settlement and $130,000 of unearned revenue. The company stated that available funds should satisfy working-capital needs for at least the next 12 months from the report date, but also warned that additional financing may be required to execute its plan and commercialize its systems.
Material changes versus the prior comparable period
- Revenue declined by $2.27 million, primarily because fewer manufacturing milestones were reached and the company had not yet recorded additional AirSCWO unit sales.
- The company moved from a gross profit of $336,501 to a gross loss of $1.11 million, including recognition of a $500,000 anticipated loss on the fixed-price equipment contract.
- Operating expenses increased by $2.44 million as the company expanded personnel, research and development, marketing and commercialization activities.
- Net loss increased by $3.41 million, while operating cash burn increased by $4.09 million.
- Cash improved because of the $13.44 million ATM equity issuance, resulting in additional dilution. Shares outstanding increased from 126.7 million to 132.7 million during 2023.
- Interest income increased to $446,669 as excess cash was held in interest-bearing accounts.
Guidance, outlook, commentary, risks and unusual items
Management expects the first commercial AirSCWO 6 unit, sold to a Southern California public agency, to be installed in the second quarter of 2024. The company expects to begin manufacturing a 30-wet-ton-per-day system in 2025 and is considering a future 200-wet-ton-per-day system. Management anticipates initial 30-wet-ton system sales within 24 months, but these expectations are forward-looking and not assured.
The original manufacturing and service agreement with Merrell Bros. will terminate on July 7, 2024 and will not be renewed. A supplemental agreement will provide manufacturing services on an as-needed basis for one year, subject to statements of work. 374Water is negotiating a lease for an approximately 50,000-square-foot facility intended to consolidate manufacturing and laboratory operations and expects to be operational at that or a similar facility on or before July 7, 2024. Failure to complete the transition could delay production and increase costs.
The company’s technology remains at an early commercial stage. Management disclosed limited operating history, no material historical revenues, limited commercial-scale operating experience and no assurance that the technology will perform successfully or become profitable. The company is searching for a permanent chief executive officer; the interim CEO and CFO each devote approximately 80% of their business time to the company.
Key risks include continued operating losses and cash burn, dependence on additional equity financing, dilution from future securities issuance, customer and government-contract concentration, reliance on Merrell Bros. and other suppliers, manufacturing and project-execution risks, required environmental permits, product defects and performance-guarantee claims, environmental liabilities, competition, intellectual-property uncertainty, cybersecurity risks and volatile trading in the common stock.
One customer represented approximately 88% of 2023 revenue and accounted for the majority of unbilled receivables. The company recorded a $135,000 accrual for a legal settlement expected to be satisfied through stock options rather than cash. A lawsuit alleging claims related to escheated shares reported combined damages of $562,500; the parties agreed in principle to a settlement involving stock options, with no cash payment by 374Water under the described terms.
Management concluded that disclosure controls and internal control over financial reporting were effective as of December 31, 2023. The auditor audited the financial statements but did not provide an attestation opinion on internal control because the company qualifies for the applicable smaller-reporting-company exemption. The filing states that no material cybersecurity incidents had occurred.
Important facts for investors to verify
- Whether the Southern California AirSCWO 6 unit was installed and accepted in the second quarter of 2024 and whether further purchase orders followed.
- The status, cost and timing of the planned manufacturing-facility transition after July 7, 2024.
- Actual cash-burn rates, remaining ATM capacity and the company’s need for additional capital.
- The final economics, timing and accounting treatment of the $500,000 contract loss provision.
- Customer concentration, collectibility of the $1.49 million unbilled receivable and the company’s ability to diversify revenue.
- Commercial-scale operating performance, permitting status and evidence supporting treatment claims for PFAS and other contaminants.
- The final resolution of the legal settlement and the number and terms of any stock options issued.
- Potential dilution from 10.83 million outstanding options, 1.24 million warrants and future equity offerings.